- Home
- ELWS vs COCP Comparison
ELWS vs COCP Comparison
Compare ELWS & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELWS
- COCP
- Stock Information
- Founded
- ELWS 2018
- COCP 2006
- Country
- ELWS Japan
- COCP United States
- Employees
- ELWS N/A
- COCP N/A
- Industry
- ELWS
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- ELWS
- COCP Health Care
- Exchange
- ELWS Nasdaq
- COCP Nasdaq
- Market Cap
- ELWS 12.9M
- COCP 15.4M
- IPO Year
- ELWS 2023
- COCP N/A
- Fundamental
- Price
- ELWS $5.80
- COCP $0.95
- Analyst Decision
- ELWS
- COCP Strong Buy
- Analyst Count
- ELWS 0
- COCP 1
- Target Price
- ELWS N/A
- COCP $6.00
- AVG Volume (30 Days)
- ELWS 61.0K
- COCP 98.6K
- Earning Date
- ELWS 09-30-2025
- COCP 11-14-2025
- Dividend Yield
- ELWS N/A
- COCP N/A
- EPS Growth
- ELWS N/A
- COCP N/A
- EPS
- ELWS N/A
- COCP N/A
- Revenue
- ELWS $3,083,071.00
- COCP N/A
- Revenue This Year
- ELWS N/A
- COCP N/A
- Revenue Next Year
- ELWS N/A
- COCP N/A
- P/E Ratio
- ELWS N/A
- COCP N/A
- Revenue Growth
- ELWS 145.52
- COCP N/A
- 52 Week Low
- ELWS $1.64
- COCP $0.90
- 52 Week High
- ELWS $10.50
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- ELWS 64.04
- COCP 38.10
- Support Level
- ELWS $5.41
- COCP $0.90
- Resistance Level
- ELWS $6.06
- COCP $1.14
- Average True Range (ATR)
- ELWS 0.52
- COCP 0.05
- MACD
- ELWS 0.07
- COCP -0.01
- Stochastic Oscillator
- ELWS 92.62
- COCP 23.83
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).